DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c37ded/pharmaceutical_dos) has announced the addition of the "Pharmaceutical ...
VANCOUVER, CANADA – FEBRUARY 16, 2016 – As next-generation drugs require perfectly aligned manufacturing processes and packaging solutions, leading suppliers have announced the creation of the Matrix ...
EWING, N.J.--(BUSINESS WIRE)-- Antares Pharma, Inc. (NAS: ATRS) today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX). The clinical trial was conducted as ...
NPS Pharmaceuticals Reports Characteristics of Patients Who Achieved Independence from Parenteral Su
BEDMINSTER, N.J.--(BUSINESS WIRE)-- NPS Pharmaceuticals, Inc. (NAS: NPSP) , a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today ...
PARSIPPANY, N.J., Oct. 31, 2017 /PRNewswire/ -- While development of a parenteral drug formulation is challenging, highly regulated, and requires high investment, the market of specialty excipients is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results